Payment overview · 2025
General Payments
$35.25
2 reported records · 2 companies
Healthcare provider profile · identity verified
Kathryn Bender, DO
Allopathic & Osteopathic Physicians|Family Medicine · DELMONT, PA · NPI 1326427543
Verified facts
What the public records show
CMS Open Payments records show Kathryn Bender, DO received $35.25 in general payments during 2025 across 2 reported records.
Boston Scientific Corporation accounted for 55.1% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $19.41 | 55.1% | 1 | 2025 |
| Kowa Pharmaceuticals America, Inc. | Unresolved — no canonical attribution shown | $15.84 | 44.9% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $35.25 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| WATCHMAN Normalized: watchman |
Device | Boston Scientific Corporation | $19.41 | 1 | 2025 |
Source payment records
|
|||||
| ZORYVE Normalized: zoryve |
Drug | Kowa Pharmaceuticals America, Inc. | $15.84 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 643 | 247 |
| Levothyroxine Sodium | Levothyroxine Sodium | 621 | 202 |
| Lisinopril | Lisinopril | 507 | 165 |
| Amlodipine Besylate | Amlodipine Besylate | 462 | 163 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 404 | 136 |
| Gabapentin | Gabapentin | 381 | 110 |
| Omeprazole | Omeprazole | 378 | 128 |
| Losartan Potassium | Losartan Potassium | 340 | 117 |
| Pantoprazole Sodium | Pantoprazole Sodium | 323 | 118 |
| Simvastatin | Simvastatin | 263 | 94 |
| Hydrochlorothiazide | Hydrochlorothiazide | 251 | 86 |
| Sertraline Hcl | Sertraline Hcl | 242 | 87 |
| Metformin Hcl | Metformin Hcl | 239 | 83 |
| Atenolol | Atenolol | 211 | 64 |
| Metoprolol Succinate | Metoprolol Succinate | 203 | 68 |
| Ozempic | Semaglutide | 203 | 45 |
| Furosemide | Furosemide | 202 | 70 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 197 | 74 |
| Duloxetine Hcl | Duloxetine Hcl | 182 | 48 |
| Fluticasone Propionate | Fluticasone Propionate | 182 | 74 |
| Metoprolol Tartrate | Metoprolol Tartrate | 174 | 56 |
| Metformin Hcl Er | Metformin Hcl | 166 | 61 |
| Tamsulosin Hcl | Tamsulosin Hcl | 166 | 49 |
| Escitalopram Oxalate | Escitalopram Oxalate | 158 | 52 |
| Famotidine | Famotidine | 158 | 66 |
| Pravastatin Sodium | Pravastatin Sodium | 158 | 56 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 133 | 45 |
| Prednisone | Prednisone | 133 | 78 |
| Trazodone Hcl | Trazodone Hcl | 133 | 44 |
| Synthroid | Levothyroxine Sodium | 122 | 37 |
| Eliquis | Apixaban | 118 | 33 |
| Montelukast Sodium | Montelukast Sodium | 114 | 36 |
| Buspirone Hcl | Buspirone Hcl | 109 | 28 |
| Jardiance | Empagliflozin | 107 | 31 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 96 | 42 |
| Clopidogrel | Clopidogrel Bisulfate | 95 | 35 |
| Fluoxetine Hcl | Fluoxetine Hcl | 94 | 33 |
| Allopurinol | Allopurinol | 89 | 24 |
| Lorazepam | Lorazepam | 89 | 31 |
| Mounjaro | Tirzepatide | 89 | 17 |
| Alendronate Sodium | Alendronate Sodium | 82 | 36 |
| Valsartan | Valsartan | 82 | 21 |
| Carvedilol | Carvedilol | 81 | 24 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 75 | 21 |
| Doxycycline Hyclate | Doxycycline Hyclate | 74 | 60 |
| Naproxen | Naproxen | 73 | 23 |
| Glipizide Er | Glipizide | 72 | 18 |
| Potassium Chloride | Potassium Chloride | 72 | 32 |
| Meloxicam | Meloxicam | 71 | 33 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 69 | 16 |
| Finasteride | Finasteride | 68 | 24 |
| Citalopram Hbr | Citalopram Hydrobromide | 67 | 25 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 67 | 36 |
| Warfarin Sodium | Warfarin Sodium | 67 | 12 |
| Celecoxib | Celecoxib | 64 | 18 |
| Ibuprofen | Ibuprofen | 59 | 28 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 59 | 20 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 57 | 12 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 56 | 12 |
| Bupropion Hcl Sr | Bupropion Hcl | 54 | 20 |
| Tramadol Hcl | Tramadol Hcl | 54 | 14 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 53 | 21 |
| Spironolactone | Spironolactone | 51 | 11 |
| Clonazepam | Clonazepam | 50 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 50 | 14 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 50 | 21 |
| Bumetanide | Bumetanide | 49 | 13 |
| Bupropion Xl | Bupropion Hcl | 49 | 14 |
| Alprazolam | Alprazolam | 48 | 12 |
| Irbesartan | Irbesartan | 48 | 17 |
| Diclofenac Sodium | Diclofenac Sodium | 44 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 44 | 16 |
| Ondansetron Hcl | Ondansetron Hcl | 43 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 42 | suppressed |
| Rybelsus | Semaglutide | 42 | suppressed |
| Cephalexin | Cephalexin | 41 | 39 |
| Tradjenta | Linagliptin | 41 | suppressed |
| Azithromycin | Azithromycin | 40 | 36 |
| Linzess | Linaclotide | 40 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 39 | 15 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 38 | 17 |
| Ropinirole Hcl | Ropinirole Hcl | 38 | 12 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 37 | suppressed |
| Xarelto | Rivaroxaban | 36 | 12 |
| Ondansetron Odt | Ondansetron | 35 | 24 |
| Sumatriptan Succinate | Sumatriptan Succinate | 35 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 34 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 34 | 26 |
| Nortriptyline Hcl | Nortriptyline Hcl | 33 | suppressed |
| Prolia | Denosumab | 33 | 21 |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 33 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 30 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 30 | 11 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 29 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 29 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 29 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 29 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 29 | 14 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 27 | 26 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 27 | 13 |
| Hydrocortisone | Hydrocortisone | 27 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 26 | 11 |
| Quetiapine Fumarate | Quetiapine Fumarate | 25 | suppressed |
| Aripiprazole | Aripiprazole | 24 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 24 | suppressed |
| Myrbetriq | Mirabegron | 24 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 24 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 24 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 23 | suppressed |
| Ezetimibe | Ezetimibe | 23 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 23 | suppressed |
| Januvia | Sitagliptin Phosphate | 23 | suppressed |
| Nyamyc | Nystatin | 23 | suppressed |
| Olanzapine | Olanzapine | 23 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 23 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 22 | suppressed |
| Methylprednisolone | Methylprednisolone | 22 | 21 |
| Nystatin | Nystatin | 22 | 11 |
| Meclizine Hcl | Meclizine Hcl | 21 | suppressed |
| Novolog Flexpen | Insulin Aspart | 21 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 21 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 20 | suppressed |
| Trulicity | Dulaglutide | 20 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 20 | 12 |
| Lansoprazole | Lansoprazole | 19 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 19 | suppressed |
| Clotrimazole | Clotrimazole | 18 | 15 |
| Tizanidine Hcl | Tizanidine Hcl | 18 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 18 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 17 | 11 |
| Ipratropium Bromide | Ipratropium Bromide | 17 | suppressed |
| Mirtazapine | Mirtazapine | 17 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 17 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 17 | suppressed |
| Ramipril | Ramipril | 17 | suppressed |
| Fluconazole | Fluconazole | 16 | 13 |
| Humalog Kwikpen U-100 | Insulin Lispro | 16 | suppressed |
| Jantoven | Warfarin Sodium | 16 | suppressed |
| Pregabalin | Pregabalin | 16 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Amoxicillin | Amoxicillin | 15 | suppressed |
| Felodipine Er | Felodipine | 15 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 15 | suppressed |
| Levetiracetam | Levetiracetam | 15 | suppressed |
| Np Thyroid | Thyroid,pork | 15 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 14 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 14 | suppressed |
| Dexamethasone | Dexamethasone | 14 | 13 |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 14 | suppressed |
| Temazepam | Temazepam | 14 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 13 | suppressed |
| Calcitriol | Calcitriol | 13 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 13 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 13 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 13 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 13 | 12 |
| Propranolol Hcl | Propranolol Hcl | 13 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 13 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 13 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 13 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 12 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 12 | suppressed |
| Ibu | Ibuprofen | 12 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 12 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 12 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 12 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 11 | suppressed |
| Glipizide | Glipizide | 11 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 11 | suppressed |
| Primidone | Primidone | 11 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 11 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 11 | suppressed |
| Repatha Syringe | Evolocumab | 11 | suppressed |
| Topiramate | Topiramate | 11 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 11 | suppressed |
| Verapamil Er | Verapamil Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $35.25 · 2 records | Boston Scientific Corporation | WATCHMAN, ZORYVE | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error